{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T01:47:11Z","timestamp":1773020831292,"version":"3.50.1"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s10354-022-00941-2","type":"journal-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T14:03:24Z","timestamp":1655733804000},"page":"87-94","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association between sex and Huntington\u2019s disease: an updated review on symptomatology and prognosis of neurodegenerative disorders","Zusammenhang zwischen Geschlecht und Huntington-Chorea: aktualisierte \u00dcbersicht zur Symptomatologie und Prognose neurodegenerativer Erkrankungen"],"prefix":"10.1007","volume":"174","author":[{"given":"Nimra","family":"Hasnain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4879-560X","authenticated-orcid":false,"given":"Taha Bin","family":"Arif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roha","family":"Shafaut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faiza","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syeda Zainab","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibtehaj Ul","family":"Haque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,20]]},"reference":[{"key":"941_CR1","volume-title":"Huntington disease","author":"A Ajitkumar","year":"2021","unstructured":"Ajitkumar\u00a0A, De Jesus\u00a0O. Huntington disease. Treasure Island (FL): StatPearls; 2021."},{"key":"941_CR2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RA Roos","year":"2010","unstructured":"Roos\u00a0RA. Huntington\u2019s disease: a\u00a0clinical review. Orphanet J Rare Dis. 2010;5:40.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"941_CR3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2007-971176","volume":"27","author":"FO Walker","year":"2007","unstructured":"Walker\u00a0FO. Huntington\u2019s disease. Semin Neurol. 2007;27(2):143\u201350.","journal-title":"Semin Neurol"},{"issue":"6","key":"941_CR4","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"No authors listed","year":"1993","unstructured":"No authors listed. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s disease collaborative research group. Cell. 1993;72(6):971\u201383.","journal-title":"Cell"},{"key":"941_CR5","doi-asserted-by":"crossref","first-page":"e4f8606b742ef3","DOI":"10.1371\/4f8606b742ef3","volume":"4","author":"O Quarrell","year":"2012","unstructured":"Quarrell\u00a0O, O\u2019Donovan\u00a0KL, Bandmann\u00a0O, Strong\u00a0M. The prevalence of juvenile Huntington\u2019s disease: a review of the literature and meta-analysis. PLoS Curr. 2012;4:e4f8606b742ef3.","journal-title":"PLoS Curr"},{"issue":"9","key":"941_CR6","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/hmg\/2.9.1467","volume":"2","author":"C Z\u00fchlke","year":"1993","unstructured":"Z\u00fchlke\u00a0C, Riess\u00a0O, Schr\u00f6der\u00a0K, Siedlaczck\u00a0I, Epplen\u00a0JT, Engel\u00a0W, et\u00a0al. Expansion of the (CAG)n repeat causing Huntington\u2019s disease in 352\u00a0patients of German origin. Hum Mol Genet. 1993;2(9):1467\u20139.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"941_CR7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/jnnp.66.1.52","volume":"66","author":"T Foroud","year":"1999","unstructured":"Foroud\u00a0T, Gray\u00a0J, Ivashina\u00a0J, Conneally\u00a0PM. Differences in duration of Huntington\u2019s disease based on age at onset. J\u00a0Neurol Neurosurg Psychiatry. 1999;66(1):52\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"941_CR8","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/hmg\/2.10.1535","volume":"2","author":"H Telenius","year":"1993","unstructured":"Telenius\u00a0H, Kremer\u00a0HP, Theilmann\u00a0J, Andrew\u00a0SE, Almqvist\u00a0E, Anvret\u00a0M, et\u00a0al. Molecular analysis of juvenile Huntington disease: the major influence on (CAG)n repeat length is the sex of the affected parent. Hum Mol Genet. 1993;2(10):1535\u201340.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"941_CR9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jmg.31.5.377","volume":"31","author":"Y Trottier","year":"1994","unstructured":"Trottier\u00a0Y, Biancalana\u00a0V, Mandel\u00a0JL. Instability of CAG repeats in Huntington\u2019s disease: relation to parental transmission and age of onset. J\u00a0Med Genet. 1994;31(5):377\u201382.","journal-title":"J Med Genet"},{"issue":"3","key":"941_CR10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1399-0004.1995.tb03941.x","volume":"47","author":"A N\u00f8rrem\u00f8lle","year":"1995","unstructured":"N\u00f8rrem\u00f8lle\u00a0A, S\u00f8rensen\u00a0SA, Fenger\u00a0K, Hasholt\u00a0L. Correlation between magnitude of CAG repeat length alterations and length of the paternal repeat in paternally inherited Huntington\u2019s disease. Clin Genet. 1995;47(3):113\u20137.","journal-title":"Clin Genet"},{"issue":"2","key":"941_CR11","first-page":"108","volume":"36","author":"P Kehoe","year":"1999","unstructured":"Kehoe\u00a0P, Krawczak\u00a0M, Harper\u00a0PS, Owen\u00a0MJ, Jones\u00a0AL. Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length. J\u00a0Med Genet. 1999;36(2):108\u201311.","journal-title":"J Med Genet"},{"issue":"11","key":"941_CR12","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/jmg.2007.050930","volume":"44","author":"VC Wheeler","year":"2007","unstructured":"Wheeler\u00a0VC, Persichetti\u00a0F, McNeil\u00a0SM, Mysore\u00a0JS, Mysore\u00a0SS, MacDonald\u00a0ME, et\u00a0al. Factors associated with HD CAG repeat instability in Huntington disease. J\u00a0Med Genet. 2007;44(11):695\u2013701.","journal-title":"J Med Genet"},{"issue":"5","key":"941_CR13","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter\u00a0WJ, Saunders\u00a0AM, Schmechel\u00a0D, Pericak-Vance\u00a0M, Enghild\u00a0J, Salvesen\u00a0GS, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S\u00a0A. 1993;90(5):1977\u201381.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"941_CR14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng0996-55","volume":"14","author":"M Miyata","year":"1996","unstructured":"Miyata\u00a0M, Smith\u00a0JD. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet. 1996;14(1):55\u201361.","journal-title":"Nat Genet"},{"issue":"2","key":"941_CR15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nm0295-135","volume":"1","author":"JA Nicoll","year":"1995","unstructured":"Nicoll\u00a0JA, Roberts\u00a0GW, Graham\u00a0DI. Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury. Nat Med. 1995;1(2):135\u20137.","journal-title":"Nat Med"},{"key":"941_CR16","doi-asserted-by":"crossref","first-page":"c3109","DOI":"10.1136\/bmj.c3109","volume":"340","author":"MJ Novak","year":"2010","unstructured":"Novak\u00a0MJ, Tabrizi\u00a0SJ. Huntington\u2019s disease. BMJ. 2010;340:c3109.","journal-title":"BMJ"},{"issue":"2","key":"941_CR17","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.parkreldis.2012.09.012","volume":"19","author":"D Zielonka","year":"2013","unstructured":"Zielonka\u00a0D, Marinus\u00a0J, Roos\u00a0RA, De Michele\u00a0G, Di Donato\u00a0S, Putter\u00a0H, et\u00a0al. The influence of gender on phenotype and disease progression in patients with Huntington\u2019s disease. Parkinsonism Relat Disord. 2013;19(2):192\u20137.","journal-title":"Parkinsonism Relat Disord"},{"key":"941_CR18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.parkreldis.2018.01.006","volume":"49","author":"D Zielonka","year":"2018","unstructured":"Zielonka\u00a0D, Ren\u00a0M, De Michele\u00a0G, Roos\u00a0RAC, Squitieri\u00a0F, Bentivoglio\u00a0AR, et\u00a0al. The contribution of gender differences in motor, behavioral and cognitive features to functional capacity, independence and quality of life in patients with Huntington\u2019s disease. Parkinsonism Relat Disord. 2018;49:42\u20137.","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"941_CR19","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11910-011-0215-x","volume":"11","author":"JS Paulsen","year":"2011","unstructured":"Paulsen\u00a0JS. Cognitive impairment in Huntington disease: diagnosis and treatment. Curr Neurol Neurosci Rep. 2011;11(5):474\u201383.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"8","key":"941_CR20","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.neuropsychologia.2006.12.015","volume":"45","author":"AC Solomon","year":"2007","unstructured":"Solomon\u00a0AC, Stout\u00a0JC, Johnson\u00a0SA, Langbehn\u00a0DR, Aylward\u00a0EH, Brandt\u00a0J, et\u00a0al. Verbal episodic memory declines prior to diagnosis in Huntington\u2019s disease. Neuropsychologia. 2007;45(8):1767\u201376.","journal-title":"Neuropsychologia"},{"issue":"5","key":"941_CR21","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1080\/01688639508405156","volume":"17","author":"JV Filoteo","year":"1995","unstructured":"Filoteo\u00a0JV, Delis\u00a0DC, Roman\u00a0MJ, Demadura\u00a0T, Ford\u00a0E, Butters\u00a0N, et\u00a0al. Visual attention and perception in patients with Huntington\u2019s disease: comparisons with other subcortical and cortical dementias. J\u00a0Clin Exp Neuropsychol. 1995;17(5):654\u201367.","journal-title":"J Clin Exp Neuropsychol"},{"issue":"2","key":"941_CR22","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1212\/WNL.54.2.452","volume":"54","author":"K Marder","year":"2000","unstructured":"Marder\u00a0K, Zhao\u00a0H, Myers\u00a0RH, Cudkowicz\u00a0M, Kayson\u00a0E, Kieburtz\u00a0K, et\u00a0al. Rate of functional decline in Huntington\u2019s disease. Huntington study group. Neurology. 2000;54(2):452\u20138.","journal-title":"Neurology"},{"issue":"1","key":"941_CR23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1212\/WNL.0b013e3181e62076","volume":"75","author":"N Saleh","year":"2010","unstructured":"Saleh\u00a0N, Moutereau\u00a0S, Azulay\u00a0JP, Verny\u00a0C, Simonin\u00a0C, Tranchant\u00a0C, et\u00a0al. High insulinlike growth factor I is associated with cognitive decline in Huntington disease. Neurology. 2010;75(1):57\u201363.","journal-title":"Neurology"},{"issue":"8","key":"941_CR24","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/mds.23385","volume":"26","author":"JL L\u00f3pez-Send\u00f3n","year":"2011","unstructured":"L\u00f3pez-Send\u00f3n\u00a0JL, Royuela\u00a0A, Trigo\u00a0P, Orth\u00a0M, Lange\u00a0H, Reilmann\u00a0R, et al. What is the impact of education on Huntington\u2019s disease? Mov Disord. 2011;26(8):1489\u201395.","journal-title":"Mov Disord"},{"issue":"2","key":"941_CR25","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/mds.21731","volume":"23","author":"ED Louis","year":"2008","unstructured":"Louis\u00a0ED, Vonsattel\u00a0JP. The emerging neuropathology of essential tremor. Mov Disord. 2008;23(2):174\u201382.","journal-title":"Mov Disord"},{"issue":"6","key":"941_CR26","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/mds.870120620","volume":"12","author":"JP Hubble","year":"1997","unstructured":"Hubble\u00a0JP, Busenbark\u00a0KL, Pahwa\u00a0R, Lyons\u00a0K, Koller\u00a0WC. Clinical expression of essential tremor: effects of gender and age. Mov Disord. 1997;12(6):969\u201372.","journal-title":"Mov Disord"},{"issue":"5","key":"941_CR27","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/mds.20096","volume":"19","author":"DE Hardesty","year":"2004","unstructured":"Hardesty\u00a0DE, Maraganore\u00a0DM, Matsumoto\u00a0JY, Louis\u00a0ED. Increased risk of head tremor in women with essential tremor: longitudinal data from the Rochester epidemiology project. Mov Disord. 2004;19(5):529\u201333.","journal-title":"Mov Disord"},{"issue":"1","key":"941_CR28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11910-017-0712-7","volume":"17","author":"G Cossu","year":"2017","unstructured":"Cossu\u00a0G, Colosimo\u00a0C. Hyperkinetic movement disorder emergencies. Curr Neurol Neurosci Rep. 2017;17(1):6.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"941_CR29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jns.2018.02.005","volume":"389","author":"D Savitt","year":"2018","unstructured":"Savitt\u00a0D, Jankovic\u00a0J. Tardive syndromes. J\u00a0Neurol Sci. 2018;389:35\u201342.","journal-title":"J Neurol Sci"},{"issue":"12","key":"941_CR30","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/jnnp-2013-307343","volume":"85","author":"E van Duijn","year":"2014","unstructured":"van Duijn\u00a0E, Craufurd\u00a0D, Hubers\u00a0AA, Giltay\u00a0EJ, Bonelli\u00a0R, Rickards\u00a0H, et\u00a0al. Neuropsychiatric symptoms in a\u00a0European Huntington\u2019s disease cohort (REGISTRY). J\u00a0Neurol Neurosurg Psychiatry. 2014;85(12):1411\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"941_CR31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jpsychores.2015.11.003","volume":"80","author":"M Dale","year":"2016","unstructured":"Dale\u00a0M, Maltby\u00a0J, Shimozaki\u00a0S, Cramp\u00a0R, Rickards\u00a0H. Disease stage, but not sex, predicts depression and psychological distress in Huntington\u2019s disease: a European population study. J\u00a0Psychosom Res. 2016;80:17\u201322.","journal-title":"J Psychosom Res"},{"issue":"9","key":"941_CR32","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.euroneuro.2011.07.018","volume":"21","author":"HU Wittchen","year":"2011","unstructured":"Wittchen\u00a0HU, Jacobi\u00a0F, Rehm\u00a0J, Gustavsson\u00a0A, Svensson\u00a0M, Jonsson\u00a0B, et\u00a0al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21(9):655\u201379.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2\u20133","key":"941_CR33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0165-0327(93)90026-G","volume":"29","author":"RC Kessler","year":"1993","unstructured":"Kessler\u00a0RC, McGonagle\u00a0KA, Swartz\u00a0M, Blazer\u00a0DG, Nelson\u00a0CB. Sex and depression in the national comorbidity survey. I: lifetime prevalence, chronicity and recurrence. J\u00a0Affect Disord. 1993;29(2\u20133):85\u201396.","journal-title":"J Affect Disord"},{"issue":"2\u20133","key":"941_CR34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.psychres.2011.09.005","volume":"196","author":"KC Rowe","year":"2012","unstructured":"Rowe\u00a0KC, Paulsen\u00a0JS, Langbehn\u00a0DR, Wang\u00a0C, Mills\u00a0J, Beglinger\u00a0LJ, et\u00a0al. Patterns of serotonergic antidepressant usage in prodromal Huntington disease. Psychiatry Res. 2012;196(2\u20133):309\u201314.","journal-title":"Psychiatry Res"},{"key":"941_CR35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40734-019-0078-x","volume":"6","author":"EM Chu","year":"2019","unstructured":"Chu\u00a0EM, O\u2019Neill\u00a0M, Purkayastha\u00a0DD, Knight\u00a0C. Huntington\u2019s disease: a\u00a0forensic risk factor in women. J\u00a0Clin Mov Disord. 2019;6:3.","journal-title":"J Clin Mov Disord"},{"issue":"19","key":"941_CR36","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1212\/01.wnl.0000334276.09729.0e","volume":"71","author":"NA Aziz","year":"2008","unstructured":"Aziz\u00a0NA, van der Burg\u00a0JM, Landwehrmeyer\u00a0GB, Brundin\u00a0P, Stijnen\u00a0T, Roos\u00a0RA. Weight loss in Huntington disease increases with higher CAG repeat number. Neurology. 2008;71(19):1506\u201313.","journal-title":"Neurology"},{"key":"941_CR37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.nut.2018.08.005","volume":"59","author":"R Costa de Miranda","year":"2019","unstructured":"Costa de Miranda\u00a0R, Di Lorenzo\u00a0N, Andreoli\u00a0A, Romano\u00a0L, De Santis\u00a0GL, Gualtieri\u00a0P, et\u00a0al. Body composition and bone mineral density in Huntington\u2019s disease. Nutrition. 2019;59:145\u20139.","journal-title":"Nutrition"},{"issue":"5","key":"941_CR38","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1523\/JNEUROSCI.11-05-01325.1991","volume":"11","author":"C Beyer","year":"1991","unstructured":"Beyer\u00a0C, Pilgrim\u00a0C, Reisert\u00a0I. Dopamine content and metabolism in mesencephalic and diencephalic cell cultures: sex differences and effects of sex steroids. J\u00a0Neurosci. 1991;11(5):1325\u201333.","journal-title":"J Neurosci"},{"issue":"7","key":"941_CR39","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0006-3223(02)01369-0","volume":"52","author":"A Laakso","year":"2002","unstructured":"Laakso\u00a0A, Vilkman\u00a0H, Bergman\u00a0J, Haaparanta\u00a0M, Solin\u00a0O, Syvalahti\u00a0E, et\u00a0al. Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects. Biol Psychiatry. 2002;52(7):759\u201363.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"941_CR40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jocn.2011.05.013","volume":"19","author":"KK Wong","year":"2012","unstructured":"Wong\u00a0KK, Muller\u00a0ML, Kuwabara\u00a0H, Studenski\u00a0SA, Bohnen\u00a0NI. Gender differences in nigrostriatal dopaminergic innervation are present at young-to-middle but not at older age in normal adults. J\u00a0Clin Neurosci. 2012;19(1):183\u20134.","journal-title":"J Clin Neurosci"},{"key":"941_CR41","volume-title":"Principles and practice of movement disorders E-book","author":"J Jankovic","year":"2021","unstructured":"Jankovic\u00a0J, Hallett\u00a0M, Okun\u00a0MS, Comella\u00a0CL, Fahn\u00a0S. Principles and practice of movement disorders E\u2011book. Elsevier; 2021."},{"key":"941_CR42","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.expneurol.2014.03.010","volume":"259","author":"M Kara","year":"2014","unstructured":"Kara\u00a0M, Smith\u00a0ND. Sex differences in Parkinson\u2019s disease and other movement disorders. Exp Neurol. 2014;259:44\u201356.","journal-title":"Exp Neurol"},{"issue":"12","key":"941_CR43","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1212\/WNL.54.12.2292","volume":"54","author":"KL Tsang","year":"2000","unstructured":"Tsang\u00a0KL, Ho\u00a0SL, Lo\u00a0SK. Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations. Neurology. 2000;54(12):2292\u20138.","journal-title":"Neurology"},{"issue":"2","key":"941_CR44","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0006-8993(97)00449-6","volume":"761","author":"CE Weaver Jr.","year":"1997","unstructured":"Weaver\u00a0CE Jr., Park-Chung\u00a0M, Gibbs\u00a0TT, Farb\u00a0DH. 17beta-estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Res. 1997;761(2):338\u201341.","journal-title":"Brain Res"},{"issue":"3","key":"941_CR45","first-page":"163","volume":"22","author":"E Hogervorst","year":"2001","unstructured":"Hogervorst\u00a0E, Williams\u00a0J, Budge\u00a0M, Barnetson\u00a0L, Combrinck\u00a0M, Smith\u00a0AD. Serum total testosterone is lower in men with Alzheimer\u2019s disease. Neuro Endocrinol Lett. 2001;22(3):163\u20138.","journal-title":"Neuro Endocrinol Lett"},{"issue":"5","key":"941_CR46","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archneur.59.5.807","volume":"59","author":"MS Okun","year":"2002","unstructured":"Okun\u00a0MS, McDonald\u00a0WM, DeLong\u00a0MR. Refractory nonmotor symptoms in male patients with Parkinson disease due to testosterone deficiency: a\u00a0common unrecognized comorbidity. Arch Neurol. 2002;59(5):807\u201311.","journal-title":"Arch Neurol"},{"issue":"1","key":"941_CR47","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-510X(01)00688-8","volume":"195","author":"A Militello","year":"2002","unstructured":"Militello\u00a0A, Vitello\u00a0G, Lunetta\u00a0C, Toscano\u00a0A, Maiorana\u00a0G, Piccoli\u00a0T, et\u00a0al. The serum level of free testosterone is reduced in amyotrophic lateral sclerosis. J\u00a0Neurol Sci. 2002;195(1):67\u201370.","journal-title":"J Neurol Sci"},{"issue":"2","key":"941_CR48","first-page":"199","volume":"28","author":"M Markianos","year":"2007","unstructured":"Markianos\u00a0M, Panas\u00a0M, Kalfakis\u00a0N, Vassilopoulos\u00a0D. Plasma testosterone, dehydroepiandrosterone sulfate, and cortisol in female patients with Huntington\u2019s disease. Neuro Endocrinol Lett. 2007;28(2):199\u2013203.","journal-title":"Neuro Endocrinol Lett"},{"issue":"3","key":"941_CR49","doi-asserted-by":"crossref","first-page":"e4962","DOI":"10.1371\/journal.pone.0004962","volume":"4","author":"N Saleh","year":"2009","unstructured":"Saleh\u00a0N, Moutereau\u00a0S, Durr\u00a0A, Krystkowiak\u00a0P, Azulay\u00a0JP, Tranchant\u00a0C, et\u00a0al. Neuroendocrine disturbances in Huntington\u2019s disease. PLoS One. 2009;4(3):e4962.","journal-title":"PLoS One"},{"issue":"4","key":"941_CR50","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/jamaneurol.2018.4377","volume":"76","author":"E De Pablo-Fern\u00e1ndez","year":"2019","unstructured":"De Pablo-Fern\u00e1ndez\u00a0E, Lees\u00a0AJ, Holton\u00a0JL, Warner\u00a0TT. Prognosis and neuropathologic correlation of clinical subtypes of parkinson disease. JAMA Neurol. 2019;76(4):470\u20139.","journal-title":"JAMA Neurol"},{"issue":"8","key":"941_CR51","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/jnnp.2006.103788","volume":"78","author":"CA Haaxma","year":"2007","unstructured":"Haaxma\u00a0CA, Bloem\u00a0BR, Borm\u00a0GF, Oyen\u00a0WJ, Leenders\u00a0KL, Eshuis\u00a0S, et\u00a0al. Gender differences in Parkinson\u2019s disease. J\u00a0Neurol Neurosurg Psychiatry. 2007;78(8):819\u201324.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"941_CR52","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/mds.1170","volume":"16","author":"MD Benedetti","year":"2001","unstructured":"Benedetti\u00a0MD, Maraganore\u00a0DM, Bower\u00a0JH, McDonnell\u00a0SK, Peterson\u00a0BJ, Ahlskog\u00a0JE, et al. Hysterectomy, menopause, and estrogen use preceding Parkinson\u2019s disease: an exploratory case-control study. Mov Disord. 2001;16(5):830\u20137.","journal-title":"Mov Disord"},{"issue":"11","key":"941_CR53","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S1474-4422(17)30328-9","volume":"16","author":"JC Latourelle","year":"2017","unstructured":"Latourelle\u00a0JC, Beste\u00a0MT, Hadzi\u00a0TC, Miller\u00a0RE, Oppenheim\u00a0JN, Valko\u00a0MP, et al. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson\u2019s disease: a\u00a0longitudinal cohort study and validation. Lancet Neurol. 2017;16(11):908\u201316.","journal-title":"Lancet Neurol"},{"key":"941_CR54","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neubiorev.2015.09.023","volume":"67","author":"RC Melcangi","year":"2016","unstructured":"Melcangi\u00a0RC, Giatti\u00a0S, Garcia-Segura\u00a0LM. Levels and actions of neuroactive steroids in the nervous system under physiological and pathological conditions: sex-specific features. Neurosci Biobehav Rev. 2016;67:25\u201340.","journal-title":"Neurosci Biobehav Rev"},{"issue":"7","key":"941_CR55","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s002590000279","volume":"27","author":"J Lavalaye","year":"2000","unstructured":"Lavalaye\u00a0J, Booij\u00a0J, Reneman\u00a0L, Habraken\u00a0JB, van Royen\u00a0EA. Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers. Eur J Nucl Med. 2000;27(7):867\u20139.","journal-title":"Eur J Nucl Med"},{"issue":"2","key":"941_CR56","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41582-019-0294-x","volume":"16","author":"S Meoni","year":"2020","unstructured":"Meoni\u00a0S, Macerollo\u00a0A, Moro\u00a0E. Sex differences in movement disorders. Nat Rev Neurol. 2020;16(2):84\u201396.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"941_CR57","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00439-007-0393-4","volume":"122","author":"L Arning","year":"2007","unstructured":"Arning\u00a0L, Saft\u00a0C, Wieczorek\u00a0S, Andrich\u00a0J, Kraus\u00a0PH, Epplen\u00a0JT. NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a\u00a0sex-specific manner. Hum Genet. 2007;122(2):175\u201382.","journal-title":"Hum Genet"},{"issue":"1","key":"941_CR58","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10048-009-0198-9","volume":"11","author":"Z Gan-Or","year":"2010","unstructured":"Gan-Or\u00a0Z, Bar-Shira\u00a0A, Mirelman\u00a0A, Gurevich\u00a0T, Kedmi\u00a0M, Giladi\u00a0N, et al. LRRK2 and GBA mutations differentially affect the initial presentation of Parkinson disease. Neurogenetics. 2010;11(1):121\u20135.","journal-title":"Neurogenetics"},{"issue":"1","key":"941_CR59","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.parkreldis.2013.09.025","volume":"20","author":"K Szewczyk-Krolikowski","year":"2014","unstructured":"Szewczyk-Krolikowski\u00a0K, Tomlinson\u00a0P, Nithi\u00a0K, Wade-Martins\u00a0R, Talbot\u00a0K, Ben-Shlomo\u00a0Y, et al. The influence of age and gender on motor and non-motor features of early Parkinson\u2019s disease: initial findings from the Oxford Parkinson disease center (OPDC) discovery cohort. Parkinsonism Relat Disord. 2014;20(1):99\u2013105.","journal-title":"Parkinsonism Relat Disord"},{"key":"941_CR60","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.parkreldis.2018.02.007","volume":"50","author":"B Cholerton","year":"2018","unstructured":"Cholerton\u00a0B, Johnson\u00a0CO, Fish\u00a0B, Quinn\u00a0JF, Chung\u00a0KA, Peterson-Hiller\u00a0AL, et al. Sex differences in progression to mild cognitive impairment and dementia in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2018;50:29\u201336.","journal-title":"Parkinsonism Relat Disord"},{"key":"941_CR61","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3389\/fneur.2020.00571","volume":"11","author":"D Zielonka","year":"2020","unstructured":"Zielonka\u00a0D, Stawinska-Witoszynska\u00a0B. Gender differences in non-sex linked disorders: insights from Huntington\u2019s disease. Front Neurol. 2020;11:571.","journal-title":"Front Neurol"},{"issue":"1","key":"941_CR62","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00415-008-0726-9","volume":"255","author":"U Beinhoff","year":"2008","unstructured":"Beinhoff\u00a0U, Tumani\u00a0H, Brettschneider\u00a0J, Bittner\u00a0D, Riepe\u00a0MW. Gender-specificities in Alzheimer\u2019s disease and mild cognitive impairment. J\u00a0Neurol. 2008;255(1):117\u201322.","journal-title":"J Neurol"},{"issue":"1\u20132","key":"941_CR63","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.brainres.2004.05.029","volume":"1017","author":"DR Howlett","year":"2004","unstructured":"Howlett\u00a0DR, Richardson\u00a0JC, Austin\u00a0A, Parsons\u00a0AA, Bate\u00a0ST, Davies\u00a0DC, et al. Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin\u20111 mutant transgenes. Brain Res. 2004;1017(1\u20132):130\u20136.","journal-title":"Brain Res"},{"issue":"6","key":"941_CR64","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archpsyc.62.6.685","volume":"62","author":"LL Barnes","year":"2005","unstructured":"Barnes\u00a0LL, Wilson\u00a0RS, Bienias\u00a0JL, Schneider\u00a0JA, Evans\u00a0DA, Bennett\u00a0DA. Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry. 2005;62(6):685\u201391.","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"941_CR65","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1212\/WNL.49.6.1498","volume":"49","author":"S Seshadri","year":"1997","unstructured":"Seshadri\u00a0S, Wolf\u00a0PA, Beiser\u00a0A, Au\u00a0R, McNulty\u00a0K, White\u00a0R, et\u00a0al. Lifetime risk of dementia and Alzheimer\u2019s disease. The impact of mortality on risk estimates in the Framingham study. Neurology. 1997;49(6):1498\u2013504.","journal-title":"Neurology"},{"issue":"9","key":"941_CR66","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1212\/WNL.53.9.1992","volume":"53","author":"K Andersen","year":"1999","unstructured":"Andersen\u00a0K, Launer\u00a0LJ, Dewey\u00a0ME, Letenneur\u00a0L, Ott\u00a0A, Copeland\u00a0JR, et\u00a0al. Gender differences in the incidence of AD and vascular dementia: the EURODEM studies. EURODEM incidence research group. Neurology. 1999;53(9):1992\u20137.","journal-title":"Neurology"},{"issue":"3","key":"941_CR67","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jalz.2013.10.005","volume":"11","author":"G Chene","year":"2015","unstructured":"Chene\u00a0G, Beiser\u00a0A, Au\u00a0R, Preis\u00a0SR, Wolf\u00a0PA, Dufouil\u00a0C, et al. Gender and incidence of dementia in the Framingham heart study from mid-adult life. Alzheimers Dement. 2015;11(3):310\u201320.","journal-title":"Alzheimers Dement"},{"key":"941_CR68","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jsbmb.2015.09.039","volume":"160","author":"R Hanamsagar","year":"2016","unstructured":"Hanamsagar\u00a0R, Bilbo\u00a0SD. Sex differences in neurodevelopmental and neurodegenerative disorders: focus on microglial function and neuroinflammation during development. J\u00a0Steroid Biochem Mol Biol. 2016;160:127\u201333.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"941_CR69","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3233\/JAD-122359","volume":"35","author":"JR Hall","year":"2013","unstructured":"Hall\u00a0JR, Wiechmann\u00a0AR, Johnson\u00a0LA, Edwards\u00a0M, Barber\u00a0RC, Winter\u00a0AS, et\u00a0al. Biomarkers of vascular risk, systemic inflammation, and microvascular pathology and neuropsychiatric symptoms in Alzheimer\u2019s disease. J\u00a0Alzheimers Dis. 2013;35(2):363\u201371.","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"941_CR70","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/ejhg.2014.281","volume":"23","author":"A Mastrokolias","year":"2015","unstructured":"Mastrokolias\u00a0A, Ariyurek\u00a0Y, Goeman\u00a0JJ, van Duijn\u00a0E, Roos\u00a0RA, van der Mast\u00a0RC, et\u00a0al. Huntington\u2019s disease biomarker progression profile identified by transcriptome sequencing in peripheral blood. Eur J Hum Genet. 2015;23(10):1349\u201356.","journal-title":"Eur J Hum Genet"},{"key":"941_CR71","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fnins.2020.00073","volume":"14","author":"J Corey-Bloom","year":"2020","unstructured":"Corey-Bloom\u00a0J, Haque\u00a0A, Aboufadel\u00a0S, Snell\u00a0C, Fischer\u00a0RS, Granger\u00a0SW, et al. Uric acid as a\u00a0potential peripheral biomarker for disease features in Huntington\u2019s patients. Front Neurosci. 2020;14:73.","journal-title":"Front Neurosci"},{"key":"941_CR72","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fnmol.2019.00335","volume":"12","author":"A Gutierrez","year":"2020","unstructured":"Gutierrez\u00a0A, Corey-Bloom\u00a0J, Thomas\u00a0EA, Desplats\u00a0P. Evaluation of biochemical and epigenetic measures of peripheral brain-derived neurotrophic factor (BDNF) as a\u00a0biomarker in Huntington\u2019s disease patients. Front Mol Neurosci. 2020;12:335.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"941_CR73","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neurobiolaging.2004.03.002","volume":"26","author":"M Lommatzsch","year":"2005","unstructured":"Lommatzsch\u00a0M, Zingler\u00a0D, Schuhbaeck\u00a0K, Schloetcke\u00a0K, Zingler\u00a0C, Schuff-Werner\u00a0P, et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging. 2005;26(1):115\u201323.","journal-title":"Neurobiol Aging"},{"key":"941_CR74","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbi.2014.09.011","volume":"44","author":"KH Chang","year":"2015","unstructured":"Chang\u00a0KH, Wu\u00a0YR, Chen\u00a0YC, Chen\u00a0CM. Plasma inflammatory biomarkers for Huntington\u2019s disease patients and mouse model. Brain Behav Immun. 2015;44:121\u20137.","journal-title":"Brain Behav Immun"},{"issue":"8","key":"941_CR75","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10654-007-9157-7","volume":"22","author":"T Pekmezovic","year":"2007","unstructured":"Pekmezovic\u00a0T, Svetel\u00a0M, Maric\u00a0J, Dujmovic-Basuroski\u00a0I, Dragasevic\u00a0N, Keckarevic\u00a0M, et al. Survival of Huntington\u2019s disease patients in Serbia: longer survival in female patients. Eur J Epidemiol. 2007;22(8):523\u20136.","journal-title":"Eur J Epidemiol"},{"issue":"9","key":"941_CR76","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1007\/s00415-012-6415-8","volume":"259","author":"JA Byars","year":"2012","unstructured":"Byars\u00a0JA, Beglinger\u00a0LJ, Moser\u00a0DJ, Gonzalez-Alegre\u00a0P, Nopoulos\u00a0P. Substance abuse may be a\u00a0risk factor for earlier onset of Huntington disease. J\u00a0Neurol. 2012;259(9):1824\u201331.","journal-title":"J Neurol"},{"issue":"8","key":"941_CR77","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/archneur.1991.00530200036015","volume":"48","author":"RH Myers","year":"1991","unstructured":"Myers\u00a0RH, Sax\u00a0DS, Koroshetz\u00a0WJ, Mastromauro\u00a0C, Cupples\u00a0LA, Kiely\u00a0DK, et\u00a0al. Factors associated with slow progression in Huntington\u2019s disease. Arch Neurol. 1991;48(8):800\u20134.","journal-title":"Arch Neurol"},{"key":"941_CR78","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbr.2017.09.026","volume":"337","author":"JK Cao","year":"2018","unstructured":"Cao\u00a0JK, Detloff\u00a0PJ, Gardner\u00a0RG, Stella\u00a0N. Sex-dependent behavioral impairments in the HdhQ350\/+ mouse line. Behav Brain Res. 2018;337:34\u201345.","journal-title":"Behav Brain Res"},{"issue":"5","key":"941_CR79","doi-asserted-by":"crossref","first-page":"e19965","DOI":"10.1371\/journal.pone.0019965","volume":"6","author":"S Pietropaolo","year":"2011","unstructured":"Pietropaolo\u00a0S, Delage\u00a0P, Cayzac\u00a0S, Crusio\u00a0WE, Cho\u00a0YH. Sex-dependent changes in social behaviors in motor pre-symptomatic R6\/1 mice. PLoS One. 2011;6(5):e19965.","journal-title":"PLoS One"},{"issue":"2","key":"941_CR80","doi-asserted-by":"crossref","first-page":"e0147583","DOI":"10.1371\/journal.pone.0147583","volume":"11","author":"DA Kuljis","year":"2016","unstructured":"Kuljis\u00a0DA, Gad\u00a0L, Loh\u00a0DH, MacDowell Kaswan\u00a0Z, Hitchcock\u00a0ON, Ghiani\u00a0CA, et\u00a0al. Sex differences in circadian dysfunction in the BACHD mouse model of Huntington\u2019s disease. PLoS One. 2016;11(2):e147583.","journal-title":"PLoS One"},{"issue":"8","key":"941_CR81","doi-asserted-by":"crossref","first-page":"e105595","DOI":"10.1371\/journal.pone.0105595","volume":"9","author":"S Corrochano","year":"2014","unstructured":"Corrochano\u00a0S, Renna\u00a0M, Osborne\u00a0G, Carter\u00a0S, Stewart\u00a0M, May\u00a0J, et al. Reducing Igf-1r levels leads to paradoxical and sexually dimorphic effects in HD mice. PLoS One. 2014;9(8):e105595.","journal-title":"PLoS One"},{"issue":"2","key":"941_CR82","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/JHD-180321","volume":"8","author":"AC Pfalzer","year":"2019","unstructured":"Pfalzer\u00a0AC, Wages\u00a0PA, Porter\u00a0NA, Bowman\u00a0AB. Striatal cholesterol precursors are altered with age in female Huntington\u2019s disease model mice. J\u00a0Huntingtons Dis. 2019;8(2):161\u20139.","journal-title":"J Huntingtons Dis"},{"key":"941_CR83","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.nbd.2014.05.004","volume":"69","author":"C Mo","year":"2014","unstructured":"Mo\u00a0C, Pang\u00a0TY, Ransome\u00a0MI, Hill\u00a0RA, Renoir\u00a0T, Hannan\u00a0AJ. High stress hormone levels accelerate the onset of memory deficits in male Huntington\u2019s disease mice. Neurobiol Dis. 2014;69:248\u201362.","journal-title":"Neurobiol Dis"},{"key":"941_CR84","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bbr.2013.07.041","volume":"253","author":"C Mo","year":"2013","unstructured":"Mo\u00a0C, Renoir\u00a0T, Pang\u00a0TY, Hannan\u00a0AJ. Short-term memory acquisition in female Huntington\u2019s disease mice is vulnerable to acute stress. Behav Brain Res. 2013;253:318\u201322.","journal-title":"Behav Brain Res"},{"issue":"4","key":"941_CR85","doi-asserted-by":"crossref","first-page":"e0194580","DOI":"10.1371\/journal.pone.0194580","volume":"13","author":"AA Polyzos","year":"2018","unstructured":"Polyzos\u00a0AA, Wood\u00a0NI, Williams\u00a0P, Wipf\u00a0P, Morton\u00a0AJ, McMurray\u00a0CT. XJB-5-131-mediated improvement in physiology and behaviour of the R6\/2 mouse model of Huntington\u2019s disease is age- and sex- dependent. PLoS ONE. 2018;13(4):e194580.","journal-title":"PLoS ONE"},{"issue":"1","key":"941_CR86","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3233\/JHD-160189","volume":"5","author":"EA Skillings","year":"2016","unstructured":"Skillings\u00a0EA, Morton\u00a0AJ. Delayed onset and reduced cognitive deficits through pre-conditioning with 3\u2011nitropropionic acid is dependent on sex and CAG repeat length in the R6\/2 mouse model of Huntington\u2019s disease. J\u00a0Huntingtons Dis. 2016;5(1):19\u201332.","journal-title":"J Huntingtons Dis"},{"issue":"4","key":"941_CR87","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s10571-020-01003-0","volume":"42","author":"F Khodagholi","year":"2022","unstructured":"Khodagholi\u00a0F, Maleki\u00a0A, Motamedi\u00a0F, Mousavi\u00a0MA, Rafiei\u00a0S, Moslemi\u00a0M. Oxytocin prevents the development of 3\u2011NP-induced anxiety and depression in male and female rats: possible interaction of OXTR and mGluR2. Cell Mol Neurobiol. 2022;42(4):1105\u201323. https:\/\/doi.org\/10.1007\/s10571-020-01003-0.","journal-title":"Cell Mol Neurobiol"},{"issue":"3","key":"941_CR88","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/gt.2015.113","volume":"23","author":"B Connor","year":"2016","unstructured":"Connor\u00a0B, Sun\u00a0Y, von Hieber\u00a0D, Tang\u00a0SK, Jones\u00a0KS, Maucksch\u00a0C. AAV1\/2-mediated BDNF gene therapy in a\u00a0transgenic rat model of Huntington\u2019s disease. Gene Ther. 2016;23(3):283\u201395.","journal-title":"Gene Ther"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-022-00941-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10354-022-00941-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-022-00941-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T16:14:47Z","timestamp":1711124087000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10354-022-00941-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,20]]},"references-count":88,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["941"],"URL":"https:\/\/doi.org\/10.1007\/s10354-022-00941-2","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,20]]},"assertion":[{"value":"9 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N.\u00a0Hasnain, T.B.\u00a0Arif, R.\u00a0Shafaut, F.\u00a0Zakaria, S.Z.\u00a0Fatima, and I.U.\u00a0Haque declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethics committee approval is not required for this type of article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}